Enhance your practice with CME and tools that focus on the management of neurological conditions.
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
ADHD Is Linked to a Broad Burden of GI Symptoms
What’s Still Missing in ADHD Care?
James Swanson, PhD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Recurrence as the Rule: BD Symptoms Persist and Cycle
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Stroke-Like Symptoms During Treatment: Safety First
Dani Cabral, MD
David Weisman, MD
Talking Through Benefits, Risks, and Patient Priorities
ADHD After 25 Years: What Have We Learned?
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Navigating the Limitations of Current BD Therapies
Borderline Biomarkers: When a Blood Test Is Not Enough
Antithrombotics and Amyloid Therapy: Balancing Risk
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.